Bupivacaine Hci And Epinephrine Injection, Solution
Product Images NDC 51662-1399

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Bupivacaine Hci And Epinephrine (NDC 51662-1399). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch Labeling (00351662139929 Sensorcaine Pouch Label)

Label for Sensorcaine with Epinephrine injection solution, concentration 0.5% 250 mg/50 mL (5 mg/mL) in a 50 mL vial. The label displays the product NDC 51662-1399-2, lot number, expiration date, usage warnings, storage instructions, and manufacturer HF Acquisition Co, LLC in Mukilteo, WA. It specifies the solution is for nerve block only and not for caudal, epidural, or spinal anesthesia.*

FDA Label Image

Case Rfid Label (00351662139936 Sensorcaine Rfid Label)

A product label for BUPIVACAINE HCI AND EPINEPHRINE injection, solution, distributed by HF Acquisition Co LLC, DBA HealthFirst in Mukilteo, WA 98275. The label features a barcode, numeric codes including serial, lot, and expiration information, and a note to see the manufacturer's package insert. The label also indicates "RX ONLY."*

FDA Label Image

Case Labeling (00351662139936 Sensorcaine Case Label)

Label for Sensorcaine with epinephrine injection solution, containing 0.5% bupivacaine (250 mg/50 mL) with epinephrine 1:200,000 as bitartrate. The vial size is 50 mL with 25 vials per box. Label includes NDC 51662-1399-3, lot number, expiration date, and manufacturer HF Acquisition Co LLC, Mukilteo, WA. Intended for nerve block via perineural route only.*

FDA Label Image

Warning (Boxed Warning)

Text panel detailing warnings, precautions, and clinical considerations for the use of bupivacaine HCl and epinephrine injection solution. It covers contraindications for certain concentrations, risk of cardiac arrest, advised clinician qualifications, management of dose-related toxicity, and specific patient cautions including pediatric use and anesthesia administration techniques.*

FDA Label Image

Dosage (Dosage)

Table presenting the dosage information for Bupivacaine HCl and Epinephrine injection solution by type of nerve block. It lists concentration percentages, dose volume (mL), dose amount (mg), and effects on motor block for local infiltration, epidural, caudal, peripheral nerves, retrobulbar, sympathetic, and dental blocks.*

FDA Label Image

How Supplied 1 (How Supplied 1)

A data table presenting product codes, units of sale, strengths, and packaging details for various vial sizes and concentrations of a pharmaceutical injection. The table includes tray and package counts, NDC numbers, and single-dose vial volumes with corresponding drug strengths expressed in mg and percentages.*

FDA Label Image

How Supplied 2 (How Supplied 2)

A data table listing multiple pharmaceutical product codes, units of sale, strengths, and package details for injectable solutions, including tray sizes and single-dose vial volumes. The table shows various concentrations and packaging formats, such as trays of 25 and packs of 5, with strengths detailed in mg per mL and vial sizes of 10 mL or 30 mL.*

FDA Label Image

How Supplied 3 (How Supplied 3)

A table presenting product codes, units of sale, strengths, and package details for two drug variations. It lists trays of 25 with NDCs for 125 mg/50 mL (0.25%) and 250 mg/50 mL (0.5%) formulations, both provided as 50 mL multiple-dose vials with corresponding NDCs.*

FDA Label Image

How Supplied 4 (How Supplied 4)

A data table presenting product codes, units of sale, strengths, and descriptions for two formulations of a drug injection solution. The first row details a 125 mg per 50 mL (0.25%) strength in 50 mL multiple-dose vials sold in trays of 25. The second row details a 250 mg per 50 mL (0.5%) strength also in 50 mL multiple-dose vials and trays of 25. Each listing includes corresponding NDC numbers.*

FDA Label Image

Indications (Indications)

Table presenting concentrations of Bupivacaine HCl and Epinephrine used for various administration types including local infiltration, peripheral nerve block, retrobulbar block, sympathetic block, lumbar epidural, caudal, epidural test dose, and dental blocks. Concentrations range from 0.25% to 0.75%, with specific notes on inclusion of epinephrine at 1:200,000 for certain uses.*

FDA Label Image

Logo (Logo)

FDA Label Image

Precautions (Precautions)

A data table listing various drug classes in one column and examples of drugs in those classes in the adjacent column. Classes include nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs with corresponding examples such as bupivacaine under local anesthetics and acetaminophen under other drugs.*

FDA Label Image

Swerialized Vial Labeling (Serialized Vial Labeling)

Clear glass vial with a red cap containing Bupivacaine HCl and Epinephrine Injection, USP, branded as Sensorcaine. The label states the concentration as 0.5% (250 mg per 50 mL), with Epinephrine at 1:200,000. It is indicated for nerve block only, and the vial size is 50 mL multiple dose. The vial is labeled for Rx (prescription) use only and distributed by HF Acquisition Co., LLC.*

FDA Label Image

Structure 1 (Structure 1)

Chemical structure of bupivacaine hydrochloride monohydrate, showing the detailed arrangement of its molecular groups including the piperidine ring, amide linkage, aromatic ring with methyl substitutions, and associated hydrochloride and water molecules.*

FDA Label Image

Structure 2 (Structure 2)

Chemical structure diagram of epinephrine, an active ingredient of BUPIVACAINE HCI AND EPINEPHRINE injection solution. The structure shows a benzene ring with hydroxyl groups, and attached side chains including a hydroxyl group and an amine group.*

FDA Label Image

Vial Label 2 (Vial Label 2)

Label for Sensorcaine (Bupivacaine HCl and Epinephrine Injection, USP) 0.5% (5 mg/mL) in a 50 mL multiple dose vial by Fresenius Kabi. Contains epinephrine 1:200,000 as bitartrate. Intended for nerve block only, not for caudal, epidural, or spinal anesthesia. Includes warnings about sulfites and storage instructions.*

FDA Label Image

Vial Front (Vial Label)

Label for Sensorcaine (Bupivacaine HCl and Epinephrine Injection, USP) showing a 0.5% strength solution with epinephrine at 1:200,000 concentration. The label indicates 250 mg per 50 mL (5 mg per mL) in a 50 mL multiple dose vial. It is specified for nerve block only and includes a warning for sulfite content. The label includes NDC 63323-463-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.